There is a well-known relationship between MS and damage to the optic nerve, but advanced, quantitative MR imaging methods have not been applied to large cohorts. Our objective was to determine whether a short imaging protocol (Ͻ10 minutes), implemented with standard hardware, could detect abnormal water diffusion in the optic nerves of patients with MS.
I
mpaired vision is extremely common in MS and may arise from damage (demyelination and axonal loss) to different components (eg, optic nerve, tract, and radiation) of the visual system. Of these components, the optic nerve is the best characterized, because ON is the presenting symptom in many cases of MS. 1, 2 Nevertheless, recent research suggests that visual dysfunction accumulates even without prior ON. This dysfunction can be detected clinically by using low-contrast letters to assess visual sensory function 3 , OCT to assess damaged or destroyed visual axons by measuring PRNFL thickness and TMV 4 , and VEPs to assess speed and amplitude of impulse conduction. 5 MR imaging can detect visual pathway damage and has been extensively investigated. MR imaging shows T2-weighted hyperintensities in optic nerves with prior ON, whereas in acute cases, postcontrast T1-weighted hyperintensities are appreciated. 6 Recently, quantitative MR imaging techniques such as magnetization transfer imaging [7] [8] [9] and diffusion-weighted imaging [10] [11] [12] [13] [14] [15] [16] have revealed time-evolving abnormalities after an attack of ON. Unfortunately, both of these techniques are time-consuming, prohibiting clinical application. DTI uses information contained in the diffusion properties of water to probe tissue microstructural abnormalities such as demyelination and axonal damage, both of which occur in ON. The most commonly reported DTI-derived indices are FA, MD, and ʈ and Ќ to the long axis of specific white matter tracts. 17 DTI studies of affected optic nerves in patients with a remote history of ON reveal reduced FA and elevated diffu-sivities as well as correlations with concurrent measurements of acuity, VEPs, and PRNFL thickness. 10, 14, 16 However, sample sizes in these studies have been low due to technical hindrances related to the small diameter (Յ3 mm) and mobility of the optic nerves and their proximity to the paranasal sinuses, which induce susceptibility-related artifacts and interfere with conventional DTI. In addition, lengthy acquisition times actually may accentuate the effects of optic nerve motion.
The goals of this study were to 1) develop and evaluate a rapid optic nerve DTI sequence performed with standard coils in a clinically acceptable timeframe (Ͻ10 minutes) and 2) relate abnormal water diffusion in the optic nerve to measures of visual sensory function and retinal structure in the largest MS cohort reported to date. This cohort includes patients who reported an attack of acute ON Ͼ6 weeks before scanning, patients without a history of clinically recognized ON, and healthy volunteers. Thus, we examined optic nerve abnormalities in a representative MS cohort rather than a cohort dominated by patients with ON. We hypothesized that DTI indices would distinguish MS optic nerves affected by prior ON from MS optic nerves without a history of ON, and from healthy optic nerves. Furthermore, we hypothesized that, at least in MS, DTI-derived measurements would correlate with visual sensory dysfunction, PRNFL thinning, and loss of TMV.
Materials and Methods

Participants
Individuals with MS were recruited from the Johns Hopkins MS Center (Baltimore, Maryland) after the examining neurologist confirmed the diagnosis and the absence of confounding ophthalmologic or neurologic diseases. Healthy volunteers were recruited from the community. Participants were not selected based on history of ON; however, scans performed Ͻ6 weeks after the onset of acute ON were excluded. OCT and visual acuity testing by using both high-and lowcontrast (Sloan) letters were performed on all participants within 30 days of MR imaging. The median time between MR imaging and OCT and visual acuity testing was 0 days (range, 0 -23 days). Before testing, all participants gave signed, informed consent, and all studies were approved by the institutional review board.
OCT and Visual Acuity Testing
PRNFL thickness, TMV, and both high-and low-contrast visual acuity scores were measured as described previously. 4 PRNFL and TMV measurements were obtained by using an OCT-3 scanner (Stratus; Carl Zeiss Meditec, Dublin, California) with the "Fast RNFL Thickness" and "Fast Macular Thickness" protocols, respectively. Participants were encouraged to use their corrective lenses when performing contrast acuity testing with Sloan letter charts (Precision Vision, La Salle, Illinois) at 100%, 2.5%, and 1.25% contrast. Results were recorded as the percentage of letters, out of 70, correctly identified.
MR Imaging Acquisition
MR imaging data were obtained on a 3T Achieva MR system (Philips, Best, the Netherlands) by using the quadrature body coil for transmission and a 16-channel neurovascular coil for reception. Data were acquired during a 442-day period between March 26, 2008, and June 11, 2009 . Multisection, fat-saturated, double-echo proton-density and T2-weighted sequences (TR/TE 1 /TE 2 ϭ 3000/10/80 ms; echotrain length, 100; nominal acquired resolution, 0.67 ϫ 0.88 mm inplane; matrix, 224 ϫ 170; section thickness, 3.35 mm; SENSE factor, 2.5; 2 averages) and T1-weighted sequences (TR/TE ϭ 774/13 ms; echo-train length, 2; nominal acquired resolution, 0.58 ϫ 0.74 mm in-plane; matrix, 260 ϫ 204; section thickness, 3 mm; SENSE factor, 2; 2 averages) were used to provide anatomic information. In the MS cohort, the T1-weighted scans were performed after the intravenous administration of 0.1 mmol/kg gadopentetate dimeglumine (Magnevist; Bayer HealthCare, Leverkusen, Germany). The sections were oriented coronal to the head, which was oblique to the orbital portion of the optic nerves in some cases. DTI was performed in the same plane as conventional MR imaging, with a pulsed-gradient, spin-echo with single-shot, echo-planarimaging readout. The nominal acquired voxel size was 1.18 ϫ 1.18 ϫ 2.5 mm, and the data were zero-padded in k-space to achieve a reconstructed in-plane resolution of 0.28 ϫ 0.28 mm. The FOV was 80 ϫ 80 mm, and 25 sections were obtained covering the anterior visual pathway from the globe to the optic chiasm. A high parallel-imaging factor (SENSE factor, 3) enabled reduced TE, and high-order shims were combined with outer volume suppression to minimize susceptibilityrelated artifacts arising from the paranasal sinuses and tissues lateral to the optic nerves, respectively. Other parameters were as follows: TR/TE ϭ 5300/55 ms, b-value ϭ 500 s/mm 2 , 15 gradient directions uniformly distributed about a sphere, and 5 minimally diffusionweighted acquisitions (b ϭ 0; actual b-value, ϳ33 s/mm 2 ) that were averaged on the scanner. Two separate DTI acquisitions were obtained and entered into the tensor calculation as independent measurements without preaveraging. No ocular fixation was used. The total scan time for the DTI acquisitions was 9 minutes 22 seconds.
MR Imaging Data Analysis
All diffusion data were processed using CATNAP. 18 Diffusionweighted images were coregistered to the first b ϭ 0 scan by using a 6 degree-of-freedom registration algorithm supplied by AIR. 19 Diffusion-weighting was corrected for the rotational component of the registration, and the tensor was calculated in the standard manner. Maps of FA, MD, Ќ , and ʈ were calculated. 17 The investigative team, which included a neuroradiologist, 2 neuro-ophthalmologists, and 4 neurologists, determined that the MD maps displayed the best contrast between the optic nerves and the surrounding CSF. Therefore, in each section where the optic nerve was visible, a trained neuro-ophthalmologist (Z.R.W.) placed ROIs circumscribing the optic nerve on the MD images. To minimize partial volume effects, the outermost voxels of the ROIs were automatically removed by using the erode function in MatLab (MathWorks, Natick, Massachusetts). Diffusivity values that were spuriously (ie, due to noise) negative were set to 0, and FA values that were spuriously Ͼ1 were set to 1. This truncation prevents nonphysiologic results while reducing bias by removing those sections. DTI indices were then averaged across all sections, weighting the section by the number of included voxels. These averaged values entered into the statistical calculations.
Statistics
Statistical calculations were performed in STATA 9.0 (Stata LP, College Station, Texas). Stability of the quantitative measurements was assessed over the study's 442-day period by using linear regression. There was no significant change in PRNFL thickness, TMV, visual acuity scores, EDSS score, 20 MSSS, 21 or age (P Ͼ .05 in all cases).
However, diffusivity values gradually trended upward over time (P ϭ .05 for MD, P ϭ .01 for ʈ , and P ϭ .07 for Ќ ), or approximately 16%/year for MD, 14% for ʈ , and 22% for Ќ . Scatterplots (data not shown) revealed the relationship to be linear. Therefore, data were preprocessed by adjusting all DTI indices to their expected value at the center date of the study (November 7, 2008) , based on the slope of a mixed effects regression by using data from both optic nerves. There was no significant change in FA over time (P ϭ .36), but the FA values were adjusted similarly for consistency.
Intrarater and Interrater Reliability
A subset of 10 consecutive datasets was analyzed. The same neuroophthalmologist analyzed 10 cases at 2 time points separated by Ͼ12 weeks; a second rater (J.N.R., MS neurologist) separately analyzed the same 10 cases. DTI indices were averaged across the right and left optic nerves, yielding a single measurement of each DTI index for each case. Bland-Altman analysis compared the results within the same rater as well as between the raters. Intraclass and interclass correlation coefficients also were calculated. To assess differences between MS cases and controls and to quantify the correlations between DTI indices and PRNFL thickness, TMV, and visual acuity, mixed effects regression models were used to account for multiple observations (ie, from 2 optic nerves per person), with a P value of 0.01 denoting statistical significance.
Results
Cohort characteristics are presented in Table 1 . There was no difference in the age distribution between MS and healthy volunteer groups (P ϭ .11, 2 test), though there was a higher proportion of women among the healthy volunteers. The overall disability level in our cohort was moderate: median EDSS score ϭ 3.5 and mean MSSS ϭ 4.8. In a linear mixed effects model accounting for age and sex, individuals with MS had decreased PRNFL thickness (P ϭ .01), decreased TMV (P ϭ .004), and worse monocular visual acuity at 1.25% (P ϭ .03) compared with healthy volunteers. Monocular visual acuity was normal at 100% (P ϭ .41) and 2.5% (P ϭ .10) contrast in both groups. None of the optic nerves in the MS cases demonstrated enhancement on postcontrast T1-weighted images. Figure 1 shows T2-weighted and DTI index maps for the right (OD, left) and left (OS, right) optic nerves in a healthy volunteer. The optic nerve is clearly visible on all images. It is brighter than the surrounding CSF in the FA and darker in all other maps and on the T2-weighted images. Images from an MS patient with remote left (OS) ON are shown in the right panels. As is typical in ON, the T2-weighted signal intensity is increased within the affected optic nerve (circle). In the same nerve, FA is lower and all directional diffusivities are higher. These results are consistent with data from prior studies of remote ON.
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Statistical Reliability
Reliability was assessed by using Bland-Altman analysis. 22 Differences among values derived by the same rater across both sessions are presented in On-line Table 1 (top). For all DTI indices, the difference between each session was Ͻ3%, and the 95% CI for the difference overlapped zero. The 95% limits of agreement indicate a threshold for detecting real differences between pairs of values for each index and were Ͻ10% for FA and approximately 15%-20% for diffusivities. Intraclass cor- relation coefficients were close to 1 for all indices, indicating excellent agreement. Bland-Altman analysis of the difference between raters is shown in On-line Table 1 (bottom). As with the intrarater analysis, all the Bland-Altman 95% CIs for the difference overlapped zero, indicating a nonsignificant deviation. The percentage of difference between raters was larger, however, up to 9.4% for Ќ but Ͻ5% otherwise. Interclass correlation coefficients were again close to 1. The 95% limits of agreement were slightly larger for the interrater analysis and indicate that differences on the order of 10% for FA and 20% for the diffusivities can be considered significant.
Cohort Analyses
We obtained usable data from 226 of the 238 (95%) optic nerves; analysis of the other 12 nerves was marred by noise. We found no associations between any of the DTI indices and age, sex, or disease duration (P Ͼ .1), so we made no adjustments for these variables. Figure 2 and On-line Table 2 present DTI indices for optic nerves with and without previous ON. The lowest FA and highest diffusivities were found in optic nerves with previous ON in patients with SPMS. However, in mixed effect models accounting for age and sex, only lower FA in SPMS compared with healthy volunteers (P ϭ .001) and participants with RRMS (P ϭ .01) was significant. These differences were persistent (P ϭ .005 and P ϭ .03, respectively) even when the analysis was restricted to optic nerves without prior ON, suggesting that damage to the optic nerves in SPMS may reflect diffuse neurodegeneration in addition to prior inflammation.
Neither regression analysis in the full MS cohort nor paired t tests comparing optic nerves in individuals with prior unilateral ON revealed differences in DTI indices between optic nerves with and without prior ON. This contrasts with findings for measures of retinal structure and low-contrast visual acuity, in which prior ON plays a major role. Specifically, mixed effects regression analysis in eyes with prior ON revealed PRNFL thinning (P Ͻ .001), loss of TMV (P Ͻ .001), and decreased visual acuity at 2.5% (P Ͻ .001) and 1.25% (P ϭ .001) contrast (but not at 100% contrast; P ϭ .16).
Mixed effects regression analysis assessed the correlation between DTI indices and OCT and visual acuity. The results are shown in Table 2 and reveal moderately strong correlations, particularly for PRNFL thickness versus FA (Fig 3A) and Ќ . We found correlation coefficients of similar magnitudes in the individual MS subgroups, but due to lower sample size, the corresponding P values were higher. Table 2 reveals that lower FA and higher diffusivities were associated with PRNFL thinning, TMV loss, and impaired visual acuity. Of the DTI indices, FA generated the strongest correlations and ʈ generated the weakest correlations. Correlations with visual acuity scores were generally weaker than with PRNFL thickness and TMV and were strongest at high contrast. These correlations weakened substantially when PRNFL was included as a covariate (On-line Table 3 ).
Finally, correlations of DTI indices with PRNFL thickness did not strongly depend on prior history of ON. For visual acuity scores, however, stronger correlations were the trend with a known history of ON (eg, FA versus 100% contrast visual acuity; Fig 3B) ; this trend was also present for TMV. However, even the strongest of these correlations-between 100% contrast visual acuity and FA in optic nerves previously affected by ON-fell after adjusting for PRNFL thickness (On-line Table 3 ).
Discussion
This study describes the largest reported cohort of healthy and MS optic nerves investigated with DTI. We developed a rapid DTI protocol that was implemented by using standard MR imaging hardware. We show DTI-derived indices that are consistent with previous reports. 10, [13] [14] [15] [16] 23 Contrary to many previous reports, but not all, 12 we did not find many significant differences between MS (with or without history of ON) and healthy volunteer optic nerves, though trends were apparent. Consistent with these trends, DTI indices in MS optic nerves correlated with measures of retinal structural damage and visual acuity scores. Here, we interpret these results in the context of literature reports and make some concluding remarks about the potential future uses of optic nerve DTI.
Technique and Technical Challenges
Technical challenges abound with DTI of the optic nerve in vivo, and many investigators have attempted to address these challenges by using highly customized sequences with purpose-designed surface coils that require long acquisition times and extensive postprocessing. 11, 13, 16, [23] [24] [25] Those sequences were designed to minimize image distortions and maximize the signal intensity-to-noise ratio, thus providing optimal results. Our goal was to devise a DTI acquisition that could be applied immediately on high-field clinical scanners with standard multichannel, phased array head coils within a clinically acceptable timeframe. We therefore recognized that some image and data compromises would be necessary.
Our analysis procedure was straightforward, and initial processing of the images, including tensor and DTI index calculation, followed a standard pipeline previously implemented in the brain. 26, 27 As shown in Fig 1, we obtained high-quality images even without explicit B0 correction. 15 Rather than by using tractography, we drew ROIs on individual images and then eroded those ROIs to limit the effects of partial volume averaging. We recognize, however, that given the oblique orientation of the optic nerves relative to the section as well as the small cross-sectional diameter of the nerves, we were unable to eliminate partial volume effects.
Compared with previous studies, our optic nerve DTI index values were generally in agreement. The SDs were slightly lower than those obtained in major cerebral white matter tracts, including the corpus callosum and optic radiations, 28, 29 but higher than those measured in the optic tract 30 ; all of these values were recorded in overlapping, but not identical, cohorts. Note, however, that DTI indices can vary across structures and are susceptible to imaging sequence parameters. 26 Thus, we believe that our results represent reasonable estimates of the true DTI indices within the optic nerves and can be used to compare cohorts and assess relationships with non-DTI measurements. 
Interpretations
Reduced anisotropy and increased diffusivity are expected in extralesional MS white matter, [31] [32] [33] and these findings do not indicate specific types of tissue damage. 34, 35 Such abnormalities also have been found in optic nerves after ON. 36 Thus, our observation of a trend in the DTI indices in this direction is not surprising. Because we only studied optic nerves that either were not previously affected by ON or in which ON had occurred at least 6 weeks earlier, we found no evidence of decreased parallel diffusivity, as has been observed in the earliest stages of acute ON. 16 Contrary to our expectations and those in the literature, we did not observe extensive DTI abnormalities in optic nerves previously affected by ON. 10, 14 It is well established that after an episode of ON, affected optic nerves show a persistent increase in T2-weighted signal intensity and are atrophic 6, 8, [37] [38] [39] ; thus, T2-weighted imaging remains the clinical standard for detecting previous ON. Nevertheless, it is clear from our correlations that there is a connection with underlying optic nerve pathology. Abnormal DTI indices are associated with PRNFL thinning; macular volume loss; and to a lesser extent, impaired visual acuity at high contrast. This last finding was contrary to our expectations, because low-contrast acuity is known to be particularly affected in patients with MS. 3 Portions of the 2 optic nerves merge after their partial decussation at the optic chiasm, so a comparison of the results obtained here with our previous measurements in the optic tracts 30 must be interpreted with caution. In the optic tract study, by using a whole-brain DTI protocol, we found that optic tract MD and Ќ were abnormally elevated and that FA was associated with both PRNFL thinning and TMV loss (but not visual acuity). Because the optic nerves and tracts are anatomically linked, it is not surprising that we found similar results with similar correlation strengths in this study.
Shortcomings
Because of the limited spatial resolution and signal intensityto-noise ratio of our acquisition, coupled with sections that were oblique rather than perpendicular to the serpentine optic nerves, we reported summary rather than section-wise measures. Thus, data from nerves previously affected by ON show an average of potentially severely damaged segments with data from other, undamaged, or less-affected segments. Moreover, the most damaged segments may have been systematically deemphasized because we included only data from sections where we could confidently identify and demarcate the optic nerve. We suspect these factors contributed to our lack of sensitivity for detecting differences between unaffected and affected optic nerves.
Two additional limitations of our study were the lack of high-resolution anatomic data for assessing cross-sectional area and volume as well as the lack of VEP measurements. Both have been shown to correlate with each other and with DTI indices 10, 16 and are useful for a comprehensive analysis of optic nerve damage in MS.
A future study would rectify these shortcomings by 1 : using unilateral rather than bilateral nerve imaging to minimize obliqueness of the imaging section relative to the nerve axis and 2 transitioning to non-EPI acquisitions or to a multishot EPI acquisition with phase correction.
Conclusions
We suggest that optic nerve DTI, as a rapid, clinical adjunct to conventional T1-and T2-weighted imaging, is less sensitive to MS-induced tissue damage than OCT and low-contrast visual acuity measurements. Although DTI indices correlated with impaired visual acuity, much of that correlation could be accounted for by PRNFL thinning. Our results thus cast some doubt on the ultimate utility of DTI techniques derived from brain acquisitions as a tool in clinical care, at least in the chronic setting.
